Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Non Operating Income (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Non Operating Income data on record, last reported at -$86.5 million in Q4 2025.

  • For Q4 2025, Non Operating Income fell 87500.0% year-over-year to -$86.5 million; the TTM value through Dec 2025 reached -$101.6 million, changed N/A, while the annual FY2025 figure was -$113.2 million, 357.05% down from the prior year.
  • Non Operating Income reached -$86.5 million in Q4 2025 per CAI's latest filing, down from -$8.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $99000.0 in Q4 2024 and bottomed at -$86.5 million in Q4 2025.